2020 Volume 53 Issue 1 Pages 8-15
Somatostatin receptor scintigraphy (SRS) is used to diagnose neuroendocrine tumors, but its clinical use in Japan remains limited. We encountered a case of pancreatic metastasis of renal cancer showing accumulation on the SRS. A 79-year-old woman underwent a left nephrectomy for cancer of the left kidney. A simple CT follow-up conducted 19 years after the operation revealed a mass-like lesion in the pancreatic body, and previous CT images were reviewed. This review showed that the dynamic CT conducted 12 years after the operation, had revealed a mass-like lesion in the pancreatic body that was heavily stained in the arterial phase, which gradually increased over time. Close examination using SRS showed increased accumulation throughout the tumor. A pancreatic neuroendocrine tumor was first suspected, and a distal pancreatectomy was performed. Histologically, the tumor contained a clear vesicle, which was diagnosed as pancreatic metastasis of renal cancer (clear cell carcinoma). SRS could indicate the accumulation in tumors other than neuroendocrine tumors; hence, caution must be exercised during the differential diagnosis of tumors with SRS.